| |
| |
|
| Insider
Information: |
Jaen Juan C. |
| Relationship: |
President |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
371,475 |
|
|
Indirect Shares
|
1,188,233 |
|
|
| Direct
Value |
$6,705,728 |
|
|
|
Indirect Value
|
$17,906,671 |
|
|
| Total
Shares |
1,559,708 |
|
|
| Total
Value |
$24,612,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -71.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chemocentryx, Inc. |
CCXI |
SVP, Drug Discovery & ... |
2013-03-08 |
30,000 |
|
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
President |
2024-02-27 |
341,475 |
2024-02-27 |
1,188,233 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2018-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
2,175,150 |
2,667,574 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2020-10-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,207,000 |
1,572,240 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2022-02-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
350,000 |
1,222,240 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2018-03-19 |
4 |
B |
$15.00 |
$999,990 |
I/I |
66,666 |
2,734,240 |
2.66 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
244,393 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2023-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
45,800 |
324,682 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
341,475 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2022-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
232,407 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• – – |
2024-02-27 |
4 |
AS |
$20.10 |
$464,953 |
I/I |
(23,132) |
1,188,233 |
0 |
% |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2021-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
19,375 |
208,768 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-19 |
4 |
AS |
$11.85 |
$184,535 |
D/D |
(15,500) |
45,000 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2019-06-27 |
4 |
B |
$7.44 |
$75,217 |
I/I |
10,106 |
2,774,346 |
2.66 |
- |
|
| RCUS |
Arcus Biosciences Inc |
President |
• • – |
2019-06-03 |
4 |
B |
$8.25 |
$82,485 |
I/I |
10,000 |
2,764,240 |
2.66 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-12-17 |
4 |
AS |
$10.95 |
$82,375 |
D/D |
(7,500) |
53,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-12-17 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
55,500 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-12-18 |
4 |
AS |
$11.05 |
$83,375 |
D/D |
(7,500) |
53,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2012-12-18 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
55,500 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-19 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
53,700 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-22 |
4 |
AS |
$11.89 |
$90,383 |
D/D |
(7,500) |
45,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-22 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
52,401 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-25 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
52,401 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-25 |
4 |
AS |
$12.04 |
$92,067 |
D/D |
(7,500) |
45,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-26 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
47,401 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-26 |
4 |
AS |
$12.22 |
$92,756 |
D/D |
(7,500) |
45,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
• – – |
2013-02-27 |
4 |
AS |
$12.55 |
$94,179 |
D/D |
(7,500) |
45,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
